We can’t show the full text here under this license. Use the link below to read it at the source.
Sarcopenic obesity and weight loss-induced muscle mass loss
Muscle loss from weight loss in people with both obesity and low muscle mass
AI simplified
Abstract
Weight loss induced by incretin-based obesity management medications results in a significant reduction in .
- The impact of fat-free mass loss on and function is currently uncertain.
- Adequate protein intake and resistance training are important for reducing fat-free mass loss during weight loss.
- Digital health and telemedicine exercise programs may help maintain muscle health while losing weight.
- The clinical importance of fat-free mass loss during weight reduction is still debated.
- Future research should focus on improving diagnostic criteria for and evaluating long-term effects of fat-free mass reduction.
AI simplified
Key numbers
9% of community-dwelling older adults
Prevalence of
Among adults aged at least 65 years.
20–40% of total weight loss
Loss During Weight Loss
Associated with .